FDA Alters COVID Vaccine Recommendations, Limiting Access for Healthy Individuals

The FDA has announced new COVID vaccine guidelines, limiting annual vaccinations to individuals over 65 and those with specific health conditions. This marks a significant shift from previous recommendations that included all individuals aged 6 months and older. The FDA will now require pharmaceutical companies to conduct randomized clinical trials for vaccines targeting healthy populations under 65. Experts express concerns about the implications for public health, vaccine access, and the potential for confusion among healthcare providers and patients. The changes may hinder timely vaccine development and could affect public trust in vaccination efforts.